Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,233,552
  • Shares Outstanding, K 2,035,753
  • Annual Sales, $ 48,300 M
  • Annual Income, $ -8,948 M
  • EBIT $ 12,215 M
  • EBITDA $ 21,815 M
  • 60-Month Beta 0.29
  • Price/Sales 2.31
  • Price/Cash Flow 9.29
  • Price/Book 5.99

Options Overview Details

View History
  • Implied Volatility 21.70% (+0.59%)
  • Historical Volatility 30.06%
  • IV Percentile 2%
  • IV Rank 1.70%
  • IV High 55.70% on 04/10/25
  • IV Low 21.11% on 12/24/25
  • Expected Move (DTE 5) 1.20 (2.19%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 28,322
  • Volume Avg (30-Day) 32,389
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 700,214
  • Open Int (30-Day) 821,044
  • Expected Range 53.44 to 55.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.71
  • Number of Estimates 10
  • High Estimate 2.23
  • Low Estimate 1.57
  • Prior Year 1.67
  • Growth Rate Est. (year over year) +2.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.22 +13.31%
on 12/02/25
55.04 -0.73%
on 12/26/25
+5.39 (+10.94%)
since 11/26/25
3-Month
42.52 +28.50%
on 10/29/25
55.04 -0.73%
on 12/26/25
+10.52 (+23.84%)
since 09/26/25
52-Week
42.52 +28.50%
on 10/29/25
63.33 -13.72%
on 03/11/25
-3.36 (-5.79%)
since 12/26/24

Most Recent Stories

More News
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology

Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from...

AZN : 92.90 (+0.49%)
PPCB : 0.5858 (-11.24%)
RHHBY : 52.5000 (-0.06%)
BMY : 54.64 (-0.13%)
The Healthcare Sector is Gaining Momentum. Watch This Stock Chart for a Reversal Setup.

Our top chart strategist is tracking a 3-candle drop pattern on AHR.

XLV : 156.05 (+0.16%)
$SPX : 6,929.94 (-0.03%)
AHR : 47.95 (-0.93%)
BMY : 54.64 (-0.13%)
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

Eliquis® (apixaban), the Nation’s #1 Prescribed Oral Blood Thinner, Soon Available for Free to Medicaid Program Agreement Provides Tariff Relief for...

BMY : 54.64 (-0.13%)
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026

Bristol Myers Squibb (NYSE: BMY) will announce results for the fourth quarter of 2025 on Thursday, February 5, 2026. Company executives will review financial results with the investment community...

BMY : 54.64 (-0.13%)
Stocks Fall Ahead of US November Payroll Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.51%....

MSTR : 158.81 (+0.06%)
IMNM : 21.71 (-2.78%)
GLXY : 23.40 (-4.22%)
BLDR : 103.99 (-0.04%)
$IUXX : 25,644.39 (-0.05%)
COIN : 236.90 (-1.18%)
ZNH26 : 112-185s (+0.06%)
OXY : 39.85 (-0.37%)
ESH26 : 6,979.25s (-0.05%)
FANG : 146.31 (-0.41%)
LYB : 43.25 (+0.89%)
$DOWI : 48,710.97 (-0.04%)
Why Bristol-Myers Squibb (BMY) Stock Is Up Today

Why Bristol-Myers Squibb (BMY) Stock Is Up Today

BMY : 54.64 (-0.13%)
Is Albemarle Stock Outperforming the Dow?

Albemarle stock continues to run ahead of the Dow, supported by largely favorable analyst views.

ALB : 150.01 (+1.01%)
$DOWI : 48,710.97 (-0.04%)
BMY : 54.64 (-0.13%)
Why Bristol-Myers Squibb (BMY) Stock Is Up Today

Why Bristol-Myers Squibb (BMY) Stock Is Up Today

BMY : 54.64 (-0.13%)
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma

The U.S. FDA assigned a target action date of April 8, 2026

BMY : 54.64 (-0.13%)
3 Unpopular Stocks with Questionable Fundamentals

3 Unpopular Stocks with Questionable Fundamentals

BFH : 76.64 (-0.05%)
CROX : 91.63 (+1.13%)
BMY : 54.64 (-0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 55.66
2nd Resistance Point 55.35
1st Resistance Point 54.99
Last Price 54.64
1st Support Level 54.33
2nd Support Level 54.02
3rd Support Level 53.66

See More

52-Week High 63.33
Fibonacci 61.8% 55.38
Last Price 54.64
Fibonacci 50% 52.93
Fibonacci 38.2% 50.47
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar